The Biology of Congenital Adrenal Hyperplasia
At a Glance
Congenital adrenal hyperplasia (CAH) is a genetic condition where the adrenal glands lack the 21-hydroxylase enzyme needed to produce cortisol. This causes a hormonal imbalance, leading to an overproduction of androgens, but it can be effectively managed with daily hormone replacement medication.
Receiving a diagnosis of Congenital Adrenal Hyperplasia (CAH) can feel overwhelming, whether it comes through a phone call after a newborn screening or after years of searching for answers about your own health [1]. It is natural to feel a mix of fear, confusion, or even grief. Please know that while CAH is a lifelong condition, it is a manageable one. With the right care and monitoring, children born with CAH grow up to lead full, active, and healthy lives as adults [1][2].
The Role of the Adrenal Glands
The adrenal glands are two small, triangle-shaped organs that sit on top of your kidneys. They act as “chemical factories,” producing essential hormones that help your body handle stress, maintain blood pressure, and balance salt and water [3].
In most cases of CAH—more than 90%—there is a shortage of a specific protein called 21-hydroxylase [4][5]. This protein is an enzyme, a tool the body uses to convert one substance into another. Without enough of this enzyme, the adrenal glands cannot complete the “recipe” for making cortisol, the body’s primary stress hormone [3][6].
The Hormonal Feedback Loop
To understand CAH, it helps to think of the body’s hormone system like a thermostat.
- Low Cortisol: Because of the enzyme deficiency, the adrenal glands cannot make enough cortisol [7].
- The Signal (ACTH): The brain senses the low cortisol levels and sends out a loud “signal” called ACTH (adrenocorticotropic hormone) to tell the adrenal glands to work harder [8][9].
- The Overgrowth: The adrenal glands try to obey this signal, but because they are missing the 21-hydroxylase “tool,” they cannot make cortisol. Instead, they grow larger (this is the hyperplasia in the name) and begin overproducing the ingredients they can make [9].
- Androgen Excess: These leftover ingredients are shunted into a different pathway, where they become androgens (male-type hormones like testosterone) [8][10].
This imbalance—too little cortisol and too many androgens—is the core biological mechanism of CAH [11].
Classical vs. Non-Classical CAH
CAH exists on a spectrum depending on how much of the enzyme is working. This is usually determined by the specific genotype (the version of the CYP21A2 gene you have) [12][13].
- Classical CAH: This is usually diagnosed at birth or in early childhood. It includes the salt-wasting form, where the body also struggles to keep enough salt, and the simple-virilizing form [12]. In girls, high androgen levels before birth can cause the external genitals to appear different (ambiguous genitalia), though the internal reproductive organs (uterus and ovaries) are typically normal [14][15].
- Non-Classical CAH: This is a milder form that may not be noticed until later in childhood or even adulthood. It often causes symptoms like early puberty, severe acne, or irregular periods [10][12].
Diagnosis and Next Steps
For newborns, the first hint of CAH often comes from a newborn screening test that looks for a hormone called 17-OHP [16]. If this is high, doctors perform further biochemical and sometimes genetic testing to confirm the diagnosis [17][18].
Modern medicine provides effective ways to replace the hormones the body cannot make. By taking daily medication, the “thermostat” is reset: the brain stops sending the loud ACTH signal, the adrenal glands stop overproducing androgens, and the body gets the cortisol it needs to stay healthy [1][9]. Current guidelines emphasize a personalized approach, focusing on long-term wellness, growth, and quality of life [1][2].
Common questions in this guide
What causes congenital adrenal hyperplasia?
What is the difference between classical and non-classical CAH?
How is CAH diagnosed in newborns?
What does the CYP21A2 gene have to do with CAH?
Can congenital adrenal hyperplasia be treated?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my/my child's test results, do we have the 'salt-wasting' or 'simple-virilizing' form of CAH?
- 2.What was the specific 17-OHP level on the newborn screen, and what does the confirmatory testing show?
- 3.Has genetic testing for the CYP21A2 gene been performed, and how does that result inform our treatment plan?
- 4.What are the immediate signs of an adrenal crisis that I should watch for?
- 5.How will you monitor my/my child's growth and hormone levels over the next year?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.
Speiser PW, Arlt W, Auchus RJ, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(11)):4043-4088 doi:10.1210/jc.2018-01865.
PMID: 30272171 - 2
Periaortic fat thickness and cardiovascular risk factors in children with congenital adrenal hyperplasia.
Akyürek N, Eklioğlu BS, Atabek ME, et al.
Cardiology in the young 2025; (35(1)):170-174 doi:10.1017/S1047951124036576.
PMID: 39790002 - 3
Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
Parsa AA, New MI
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.
PMID: 27380651 - 4
The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.
Liu Y, Zheng J, Liu N, et al.
Molecular genetics & genomic medicine 2020; (8(11)):e1501 doi:10.1002/mgg3.1501.
PMID: 32959514 - 5
The uncommon forms of congenital adrenal hyperplasia.
Auchus RJ
Current opinion in endocrinology, diabetes, and obesity 2022; (29(3)):263-270 doi:10.1097/MED.0000000000000727.
PMID: 35621178 - 6
Bone Mineral Content and Density in Indian Children with Congenital Adrenal Hyperplasia.
Ganesh R, Suresh N, Janakiraman L
Indian pediatrics 2018; (55(10)):880-882.
PMID: 29941696 - 7
Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods.
Podgórski R, Aebisher D, Stompor M, et al.
Acta biochimica Polonica 2018; (65(1)):25-33 doi:10.18388/abp.2017_2343.
PMID: 29543924 - 8
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.
Miller WL
European journal of endocrinology 2018; (179(3)):R125-R141.
PMID: 29880708 - 9
Management challenges and therapeutic advances in congenital adrenal hyperplasia.
Mallappa A, Merke DP
Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.
PMID: 35411073 - 10
Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.
Loli P, Menotti S, di Filippo L, Giustina A
Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.
PMID: 40699527 - 11
11-Oxygenated androgens in health and disease.
Turcu AF, Rege J, Auchus RJ, Rainey WE
Nature reviews. Endocrinology 2020; (16(5)):284-296 doi:10.1038/s41574-020-0336-x.
PMID: 32203405 - 12
Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.
Fernández CS, Taboas M, Bruque CD, et al.
Clinical endocrinology 2020; (93(1)):19-27 doi:10.1111/cen.14190.
PMID: 32289882 - 13
Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.
Concolino P
Molecular diagnosis & therapy 2019; (23(5)):563-567 doi:10.1007/s40291-019-00415-z.
PMID: 31317337 - 14
Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns
Yavaş Abalı Z, Kurnaz E, Güran T
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.
PMID: 39713885 - 15
Congenital adrenal hyperplasia.
El-Maouche D, Arlt W, Merke DP
Lancet (London, England) 2017; (390(10108)):2194-2210 doi:10.1016/S0140-6736(17)31431-9.
PMID: 28576284 - 16
Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia.
Vats P, Dabas A, Jain V, et al.
Indian pediatrics 2020; (57(1)):49-55.
PMID: 31937698 - 17
Adrenal adenoma secreting 17-hydroxyprogesterone mimicking non-classical 21-hydroxylase deficiency.
Woźniak B, Leszczyńska D, Szatko A, et al.
Frontiers in endocrinology 2024; (15()):1499836 doi:10.3389/fendo.2024.1499836.
PMID: 39640880 - 18
Congenital Adrenal Hyperplasia.
Török D
Experientia supplementum (2012) 2019; (111()):245-260 doi:10.1007/978-3-030-25905-1_12.
PMID: 31588535
This page explains the biology of congenital adrenal hyperplasia for educational purposes only and does not replace professional medical advice. Always consult your endocrinologist regarding your or your child's specific diagnosis and care plan.
Get notified when new evidence is published on Congenital adrenal hyperplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.